This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rosenkrantz, H. Articles by Metterville, J.J. Search for Related Content PubMed Articles by Rosenkrantz, H. Articles by Metterville, J.J. Social Bookmarking                         What's this?

Preliminary Toxicity Data on New Ethylenediamine Derivatives Designed for Iron Chelation

EG&G Mason Research Institute 57 Union Street Worcester, MA 01608

J.J. Metterville

EG&G Mason Research Institute 57 Union Street Worcester, MA 01608

During development of iron chelators for the treatment of iron overload in Cooley's anemia, the opportunity arose to obtain some acute and subacute toxicity data on hydroxybenzyl-ethylenediamine (HBED) derivatives, hydroxyphenyl-ethylenediamine (HPED) congeners, and ethylenediamine-phenylacetic acid (EDHPA) compounds. Such data permitted correlations among structure, toxicity, and efficacy parameters useful for further syntheses. Young, adult male mice were used to perform acute intraperitoneal (IP) or oral (PO) LD₅₀ studies, and hypertransfused groups were treated IP or PO with vehicle, Desferal, or test chelators once daily for 7 days. Changes in behavior, weights of spleen, liver, and feces, and urine volume and gross pathology were monitored. In the HBED series, esterification of acetic acid groups with or without acetylation of phenolic hydroxyl groups increased LD₅₀ values, and the major behavioral change was decreased exploratory activity. Dimethylenephosphonate derivatives of HBED were more toxic. Single treatment with compounds in the EDHPA and HPED series yielded IP LD₅₀ values between 175 and 325 mg/kg. After subacute treatment, active compounds were found in each series, and efficacy was related to toxicity. Chelation effectiveness was usually greater by the IP route than orally. The major toxic signs were reduction in organ weights and excreta output.

International Journal of Toxicology, Vol. 7, No. 5, 617-629 (1988)
DOI: 10.3109/10915818809019538


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?